Stock Quote
Verenium Corporation (VRNM.W) (NASD ADF)
$4.39
20 Nov 2009
-2.88%
$4.52
$4.39
100
$4.39
$4.39
$18.60
$2.76
1.48
102,548
VRNM.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Cavanaugh, James | Chairman of the Board | -- |
| Riva, Carlos | President, Chief Executive Officer, Director | 2,740,920 |
| Levine, James | Chief Financial Officer, Executive Vice President | -- |
Profile
Verenium Corporation (Verenium), possesses a portfolio of specialty enzyme products and is developing technical and operational capabilities designed to enable the production of low-cost, biomass-derived sugars for a number of industrial applications, including the commercialization of biofuels. The... Full Description
Company Address
Verenium Corporation
55 Cambridge Parkway
Cambridge MA 02142
P: +1617.6745300
55 Cambridge Parkway
Cambridge MA 02142
P: +1617.6745300
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Maxygen, Inc. | $5.62 | 0.00 |
| Evotec AG | €2.09 | -0.01 |
| Myriad Genetics, Inc. | $23.80 | +0.20 |
| VRNM.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.80 |
| P/S(TTM) | 0.60 | 29.90 |
| ROI(TTM) | -118.89 | 2.35 |
| ROE(TTM) | -783.77 | 3.59 |
| Consensus Recommendation | Buy |
|---|---|
| EPS Est. (Current Period) | -0.94 |
| EPS Est. (Current Year) | -5.73 |
| Total Revenue | $16.29M |
| Net Income | $-28.89M |
| EPS | $-2.65 |
